Value of contrast-enhanced endoscopic ultrasonography in the differential diagnosis of mass-type chronic pancreatitis and pancreatic cancer: A Meta-analysis / 临床肝胆病杂志

ABSTRACT

ObjectiveTo systematically evaluate the value of contrast-enhanced endoscopic ultrasonography (CE-EUS) in the differential diagnosis of mass-type chronic pancreatitis and pancreatic cancer. MethodsCNKI, Wanfang Data, CBM, PubMed, Embase, and the Cochrane Library were searched for Chinese and English articles on the value of CE-EUC in the differential diagnosis of mass-type chronic pancreatitis and pancreatic cancer published up to December 31, 2018. Secondary screening, scoring, and data extraction were performed, and then Meta-Disc1.4 and stata12.0 software were used for meta-analysis. ResultsA total of 20 articles with 1888 patients were included in this study. The meta-analysis showed that in the differential diagnosis of mass-type chronic pancreatitis and pancreatic cancer, CE-EUS had a pooled sensitivity of 86% (95% confidence interval ［CI］ 83%-89%), a specificity of 93% (95%CI 92%-95%), a positive likelihood ratio of 12.01 (95%CI 9.72-14.85), a negative likelihood ratio of 0.16 (95%CI 0.10-0.26), a diagnostic odds ratio of 76.12 (95%CI 54.50-106.31), and an area under the summary receiver operating characteristic curve of 0.965 5. No sources of heterogeneity were found in the threshold effect test, the meta-regression analysis, and the sensitivity analysis. After the four articles causing heterogeneity were excluded, the heterogeneity of all included articles was reduced to an acceptable range, and there were no significant changes in the results of the meta-analysis. ConclusionCE-EUS has a good value in the differential diagnosis of mass-type chronic pancreatitis and pancreatic cancer, and its application in clinical practice can improve the diagnostic rate of pancreatic cancer.